Prio Wealth Limited Partnership’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.14M | Buy |
2,411
+11
| +0.5% | +$9.89K | 0.06% | 112 |
|
|
2024
Q2 | $2.17M | Sell |
2,400
-347
| -13% | -$278K | 0.06% | 112 |
|
|
2024
Q1 | $2.14M | Buy |
2,747
+429
| +19% | +$305K | 0.06% | 116 |
|
|
2023
Q4 | $1.35M | Hold |
2,318
| – | – | 0.05% | 129 |
|
|
2023
Q3 | $1.25M | Sell |
2,318
-34
| -1% | -$17.5K | 0.05% | 130 |
|
|
2023
Q2 | $1.1M | Buy |
2,352
+170
| +8% | +$71.3K | 0.04% | 137 |
|
|
2023
Q1 | $749K | Sell |
2,182
-346
| -14% | -$117K | 0.03% | 154 |
|
|
2022
Q4 | $925K | Sell |
2,528
-118
| -4% | -$41.8K | 0.04% | 142 |
|
|
2022
Q3 | $856K | Buy |
2,646
+109
| +4% | +$34.5K | 0.04% | 142 |
|
|
2022
Q2 | $823K | Sell |
2,537
-125
| -5% | -$37.5K | 0.03% | 151 |
|
|
2022
Q1 | $762K | Sell |
2,662
-9
| -0.3% | -$2.32K | 0.03% | 159 |
|
|
2021
Q4 | $738K | Sell |
2,671
-107
| -4% | -$27.1K | 0.02% | 165 |
|
|
2021
Q3 | $642K | Sell |
2,778
-30
| -1% | -$7.4K | 0.02% | 172 |
|
|
2021
Q2 | $644K | Sell |
2,808
-134
| -5% | -$26.9K | 0.02% | 168 |
|
|
2021
Q1 | $550K | Sell |
2,942
-723
| -20% | -$141K | 0.02% | 175 |
|
|
2020
Q4 | $619K | Buy |
3,665
+134
| +4% | +$20K | 0.02% | 166 |
|
|
2020
Q3 | $523K | Sell |
3,531
-250
| -7% | -$38.7K | 0.02% | 167 |
|
|
2020
Q2 | $621K | Sell |
3,781
-800
| -17% | -$123K | 0.03% | 157 |
|
|
2020
Q1 | $635K | Sell |
4,581
-350
| -7% | -$48.1K | 0.04% | 143 |
|
|
2019
Q4 | $648K | Buy |
4,931
+326
| +7% | +$37.8K | 0.03% | 158 |
|
|
2019
Q3 | $515K | Sell |
4,605
-346
| -7% | -$38.5K | 0.02% | 173 |
|
|
2019
Q2 | $548K | Sell |
4,951
-25
| -0.5% | -$2.94K | 0.03% | 165 |
|
|
2019
Q1 | $645K | Sell |
4,976
-265
| -5% | -$32.2K | 0.03% | 157 |
|
|
2018
Q4 | $606K | Hold |
5,241
| – | – | 0.03% | 152 |
|
|
2018
Q3 | $562K | Buy |
5,241
+18
| +0.3% | +$1.8K | 0.03% | 167 |
|
|
2018
Q2 | $445K | Buy |
5,223
+7
| +0.1% | +$575 | 0.02% | 173 |
|
|
2018
Q1 | $403K | Buy |
5,216
+500
| +11% | +$40.3K | 0.02% | 178 |
|
|
2017
Q4 | $398K | Hold |
4,716
| – | – | 0.02% | 184 |
|
|
2017
Q3 | $403K | Buy |
4,716
+100
| +2% | +$8.2K | 0.02% | 181 |
|
|
2017
Q2 | $379K | Hold |
4,616
| – | – | 0.02% | 184 |
|
|
2017
Q1 | $388K | Sell |
4,616
-100
| -2% | -$8.01K | 0.02% | 184 |
|
|
2016
Q4 | $346K | Hold |
4,716
| – | – | 0.02% | 192 |
|
|
2016
Q3 | $378K | Hold |
4,716
| – | – | 0.02% | 196 |
|
|
2016
Q2 | $371K | Hold |
4,716
| – | – | 0.02% | 186 |
|
|
2016
Q1 | $339K | Sell |
4,716
-100
| -2% | -$7.57K | 0.02% | 199 |
|
|
2015
Q4 | $405K | Hold |
4,816
| – | – | 0.02% | 187 |
|
|
2015
Q3 | $403K | Buy |
4,816
+800
| +20% | +$67.5K | 0.02% | 185 |
|
|
2015
Q2 | $335K | Hold |
4,016
| – | – | 0.02% | 208 |
|
|
2015
Q1 | $291K | Hold |
4,016
| – | – | 0.01% | 218 |
|
|
2014
Q4 | $277K | Sell |
4,016
-1,463
| -27% | -$98.8K | 0.01% | 221 |
|
|
2014
Q3 | $355K | Hold |
5,479
| – | – | 0.02% | 198 |
|
|
2014
Q2 | $340K | Hold |
5,479
| – | – | 0.02% | 204 |
|
|
2014
Q1 | $322K | Sell |
5,479
-1,200
| -18% | -$67K | 0.02% | 208 |
|
|
2013
Q4 | $340K | Hold |
6,679
| – | – | 0.02% | 202 |
|
|
2013
Q3 | $336K | Hold |
6,679
| – | – | 0.02% | 202 |
|
|
2013
Q2 | $328K | Buy |
+6,679
| New | +$363K | 0.02% | 196 |
|
Other funds holding LLY
Prio Wealth Limited Partnership's LLY Position: Q3 2024 in Review
Prio Wealth Limited Partnership increased its Eli Lilly (LLY) stake by 0.46% in Q3 2024, buying an estimated $9.89K and bringing the position to 2,411 shares worth $2.14M. The position accounts for 0.06% of the portfolio, ranked #112.
Prio Wealth Limited Partnership first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.17M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Prio Wealth Limited Partnership held 2,411 shares of Eli Lilly worth $2.14M as of Q3 2024.
- Prio Wealth Limited Partnership bought 11 Eli Lilly shares in Q3 2024, an estimated $9.89K.
- Eli Lilly made up 0.06% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #112 holding.
- Prio Wealth Limited Partnership first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
- Prio Wealth Limited Partnership's Eli Lilly position peaked at $2.17M in Q2 2024.
- 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.